Prognostic value of diabetes and metformin use in a real-life population of head and neck cancer patients.

De Falco, Vincenzo; Vitale, Pasquale; Brancati, Christian; Cicero, Giuseppe; Auriemma, Annunziata; Addeo, Raffaele

De Falco, Vincenzo; Vitale, Pasquale; Brancati, Christian; Cicero, Giuseppe; Auriemma, Annunziata; Addeo, Raffaele.

Afiliación

De Falco V; Medical Oncology Unit, San Giovanni di Dio Hospital, Frattamaggiore, Italy.
Vitale P; Medical Oncology Unit, San Giovanni di Dio Hospital, Frattamaggiore, Italy.
Brancati C; Medical Oncology Unit, San Giovanni di Dio Hospital, Frattamaggiore, Italy.
Cicero G; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
Auriemma A; Medical Oncology Unit, San Giovanni di Dio Hospital, Frattamaggiore, Italy.
Addeo R; Medical Oncology Unit, San Giovanni di Dio Hospital, Frattamaggiore, Italy.

Front Med (Lausanne) ; 10: 1252407, 2023.

Article en En | MEDLINE | ID: mdl-37746082

Palabras clave

HNC; HNSCC; diabetes; head and neck cancer; metformin; oral cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Front Med (Lausanne) Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google